BIOFARM
96 articole · RSS
Biofarm Invests in New Products in Next Two Years
Biofarm Bucuresti, one of the ten largest local drug manufacturers, has earmarked investments in its own drug brands, but also in new products it is set to launch on the market.
Biofarm Ends H1, 2025 With Almost RON49M Net Profit
Drug manufacturer Biofarm (BIO.RO) posted sales revenue of RON162.9 million in the first half of 2025, up 15% from the same period in 2024, while net profit increased by 16% to RON48.8 milli...
Biofarm Plans To Retool First Plant In Bucharest
Biofarm, one of the leading pharmaceutical producers in Romania, which has two plants in Bucharest, plans to invest in retooling its first facility and develop a new research and development...
Biofarm Reaches RON95M Turnover in Q1/2025, Up 33% YOY
Pharma producer Biofarm in the first quarter of 2025 registered sales revenues of RON95 million, up 33%, and RON32 million net profit, 57% above the Q1/2024 level.
Biofarm To Pay Out RON31M Worth Of Dividends From Its 2024 Net Profit
Shareholders of pharmaceutical producer Biofarm (BIO.RO) approved at their general meeting on April 28 the distribution of the company's net profit of RON74.4 million for 2024, as per a repo...
Biofarm Plans To Distribute RON31M Dividends From 2024’s Profit
Pharmaceutical producer Biofarm (BIO.RO), has called shareholders for extraordinary and ordinary general meetings on April 29 to vote among others for the distribution of the RON74.4 million...
Biofarm Ends Jan-Sept 2024 Period With RON73M Net Profit And RON231M Sales
Pharmaceutical producer Biofarm Bucuresti (stock symbol: BIO) ended the first nine months of 2024 with net profit of RON73.25 million, at an individual level, up 4.7% from the same period of...
Biofarm's Net Profit Shrinks 35% YoY To RON20.6M In Q1/2024
Pharmaceutical producer Biofarm Bucuresti (BIO.RO) ended the first three months of 2024 with net profit of RON20.6 million, down almost 35% from the same period of 2023, as per its quarterly...
Biofarm Shareholders Approve Distribution Of Dividends Worth Over RON30M, With 3.8% Yield
In their ordinary general meeting of April 24, the shareholders of pharmaceutical producer Biofarm Bucuresti (BIO.RO) approved, among others, the financial statements for 2023, the budget of...